207 related articles for article (PubMed ID: 36555953)
1. Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis.
Espina S; Sanz-Paris A; Bernal-Monterde V; Casas-Deza D; Arbonés-Mainar JM
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36555953
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-hydroxy-beta-methylbutyrate supplementation on skeletal muscle in healthy and cirrhotic rats.
Holeček M; Vodeničarovová M
Int J Exp Pathol; 2019 Jun; 100(3):175-183. PubMed ID: 31321841
[TBL] [Abstract][Full Text] [Related]
3. Randomized Clinical Trial: Effects of β-Hydroxy-β-Methylbutyrate (HMB)-Enriched vs. HMB-Free Oral Nutritional Supplementation in Malnourished Cirrhotic Patients.
Espina S; Sanz-Paris A; Gonzalez-Irazabal Y; Pérez-Matute P; Andrade F; Garcia-Rodriguez B; Carpéné C; Zakaroff A; Bernal-Monterde V; Fuentes-Olmo J; Arbones-Mainar JM
Nutrients; 2022 Jun; 14(11):. PubMed ID: 35684144
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy.
Espina S; Gonzalez-Irazabal Y; Sanz-Paris A; Lopez-Yus M; Garcia-Sobreviela MP; Del Moral-Bergos R; Garcia-Rodriguez B; Fuentes-Olmo J; Bernal-Monterde V; Arbones-Mainar JM
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836020
[TBL] [Abstract][Full Text] [Related]
5. Metabolic flux analysis of branched-chain amino and keto acids (BCAA, BCKA) and β-hydroxy β-methylbutyric acid across multiple organs in the pig.
Ten Have GAM; Jansen L; Schooneman MG; Engelen MPKJ; Deutz NEP
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E629-E640. PubMed ID: 33522397
[TBL] [Abstract][Full Text] [Related]
6. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.
Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A
Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059
[TBL] [Abstract][Full Text] [Related]
7. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
Holecek M
Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
[TBL] [Abstract][Full Text] [Related]
8. The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study.
Lattanzi B; Bruni A; Di Cola S; Molfino A; De Santis A; Muscaritoli M; Merli M
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371806
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acid enriched supplements as therapy for liver disease.
Charlton M
J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.
Konstantis G; Pourzitaki C; Chourdakis M; Kitsikidou E; Germanidis G
Clin Nutr; 2022 Jun; 41(6):1171-1190. PubMed ID: 35500317
[TBL] [Abstract][Full Text] [Related]
11. Late evening snacks with branched-chain amino acids improve the Fischer ratio with patients liver cirrhosis at fasting in the next morning.
Maki H; Yamanaka-Okumura H; Katayama T; Ozawa Y; Hosoda A; Kurata N; Amemiya F
Clin Nutr ESPEN; 2019 Apr; 30():138-144. PubMed ID: 30904214
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
13. Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review.
Ooi PH; Gilmour SM; Yap J; Mager DR
Clin Nutr ESPEN; 2018 Dec; 28():41-51. PubMed ID: 30390892
[TBL] [Abstract][Full Text] [Related]
14. Branched chain amino acid therapy in liver disease.
Maddrey WC
J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
[TBL] [Abstract][Full Text] [Related]
15. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation.
Holeček M
Nutrition; 2017 Sep; 41():80-85. PubMed ID: 28760433
[TBL] [Abstract][Full Text] [Related]
16. The role of Branched Chain Amino Acids in the treatment of hepatic Encephalopathy.
Dam G; Aamann L; Vistrup H; Gluud LL
J Clin Exp Hepatol; 2018 Dec; 8(4):448-451. PubMed ID: 30568347
[TBL] [Abstract][Full Text] [Related]
17. The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases.
Holeček M
Physiol Res; 2021 Jul; 70(3):293-305. PubMed ID: 33982576
[TBL] [Abstract][Full Text] [Related]
18. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
[TBL] [Abstract][Full Text] [Related]
19. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.
Holeček M
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):529-541. PubMed ID: 28493406
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis.
Moriwaki H; Shiraki M; Fukushima H; Shimizu M; Iwasa J; Naiki T; Nagaki M
Hepatol Res; 2008 Nov; 38 Suppl 1():S102-6. PubMed ID: 19125940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
